title: Characterization of the tritium-labeled analog of L-threo-beta-benzyloxyaspartate binding to glutamate transporters.
abstract: L-Glutamate is the major excitatory neurotransmitter in the mammalian central nervous system. Termination of glutamate receptor activation and maintenance of low extracellular glutamate concentrations are primarily achieved by glutamate transporters (excitatory amino acid transporters 1-5, EAATs1-5) located on both the nerve endings and the surrounding glial cells. To identify the physiological roles of each subtype, subtype-selective EAAT ligands are required. In this study, we developed a binding assay system to characterize EAAT ligands for all EAAT subtypes. We recently synthesized novel analogs of threo-beta-benzyloxyaspartate (TBOA) and reported that they blocked glutamate uptake by EAATs 1-5 much more potently than TBOA. The strong inhibitory activity of the TBOA analogs suggested that they would be suitable to use as radioisotope-labeled ligands, and we therefore synthesized a tritiated derivative of (2S,3S)-3-{3-[4-ethylbenzoylamino]benzyloxy}aspartate ([3H]ETB-TBOA). [3H]ETB-TBOA showed significant high-affinity specific binding to EAAT-transfected COS-1 cell membranes with each EAAT subtype. The Hill coefficient for the Na+-dependence of [3H]ETB-TBOA binding revealed a single class of noncooperative binding sites for Na+, suggesting that Na+ binding in the ligand binding step is different from Na+ binding in the substrate uptake process. The binding was displaced by known substrates and blockers. The rank order of inhibition by these compounds was consistent with glutamate uptake assay results reported previously. Thus, the [3H]ETB-TBOA binding assay will be useful to screen novel EAAT ligands for all EAAT subtypes.
authors.affiliation: Suntory Institute for Bioorganic Research, 1-1-1, Wakayamadai, Mishima-gun, Osaka 618-8503, USA. shimamot@sunbor.or.jp
authors.forename: Keiko
authors.initials: K
authors.lastname: Shimamoto
authors.forename: Yasuto
authors.initials: Y
authors.lastname: Otsubo
authors.forename: Yasushi
authors.initials: Y
authors.lastname: Shigeri
authors.forename: Yoshimi
authors.initials: Y
authors.lastname: Yasuda-Kamatani
authors.forename: Masamichi
authors.initials: M
authors.lastname: Satoh
authors.forename: Shuji
authors.initials: S
authors.lastname: Kaneko
authors.forename: Takayuki
authors.initials: T
authors.lastname: Nakagawa
mesh_terms: D027322:Amino Acid Transport System X-AG / Q000378:metabolism*; D000818:Animals; D001224:Aspartic Acid / Q000378:metabolism; D019556:COS Cells; D002522:Chlorocebus aethiops; D027341:Excitatory Amino Acid Transporter 1 / Q000378:metabolism; D027342:Excitatory Amino Acid Transporter 2; D050580:Excitatory Amino Acid Transporter 3 / Q000378:metabolism; D050491:Glutamate Plasma Membrane Transport Proteins / Q000378:metabolism; D018698:Glutamic Acid / Q000378:metabolism; D006801:Humans; D007700:Kinetics; D011485:Protein Binding; D011865:Radioisotope Dilution Technique; D011994:Recombinant Proteins / Q000378:metabolism; D012964:Sodium / Q000378:metabolism; D014162:Transfection; D014316:Tritium
chemical_list: D027322:Amino Acid Transport System X-AG; D027341:Excitatory Amino Acid Transporter 1; D027342:Excitatory Amino Acid Transporter 2; D050580:Excitatory Amino Acid Transporter 3; D050491:Glutamate Plasma Membrane Transport Proteins; D011994:Recombinant Proteins; C493400:SLC1A1 protein, human; C493397:SLC1A2 protein, human; C493394:SLC1A3 protein, human; C120673:benzyloxyaspartate; D014316:Tritium; D001224:Aspartic Acid; D018698:Glutamic Acid; D012964:Sodium